Impact of magnesium supplementation, in combination with vitamin B6, on stress and magnesium status: secondary data from a randomized controlled trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

This secondary analysis investigated the impact of magnesium and vitamin B6 supplementation and perceived stress on erythrocyte magnesium levels, as a marker of body magnesium status.

Stress level and erythrocyte magnesium level at baseline, and change in erythrocyte magnesium and serum vitamin B6 levels at weeks 4 and 8, were analyzed.

Who Took Part

The study group was 264 subjects.

The age groups tagged for this paper are teenagers, young adults, adults and middle-aged adults.

Overall, 264 subjects were randomized to treatment and had evaluable Depression Anxiety Stress Scale scores (132 in each treatment arm).

How the Study Was Run

In design terms this was a randomized study.

The subjects were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

What Was Measured

This secondary analysis investigated the impact of magnesium and vitamin B6 supplementation and perceived stress on erythrocyte magnesium levels, as a marker of body magnesium status.

Stress level and erythrocyte magnesium level at baseline, and change in erythrocyte magnesium and serum vitamin B6 levels at weeks 4 and 8, were analyzed.

PubMed files the paper under topics including Dietary Supplements, Magnesium and Vitamin B 6.

The authors tagged it with the keywords biomarkers of magnesium status, magnesium supplementation, perceived stress, randomized controlled trial and vitamin B6 supplementation.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 264 subjects.

The publication is from 2020 (Magnesium research), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.